Due to a system-wide technology update, we are experiencing extremely high call volume. We appreciate your patience with our operators during this time. Thank you for choosing Fox Chase Cancer Center.
Fox Chase’s Paul F. Engstrom, MD, to Receive Association of Community Cancer Centers Annual Clinical Care Achievement Award
PHILADELPHIA, PA (September 6, 2013)—Paul F. Engstrom, MD, Acting Chairman of Medical Oncology and Senior Vice President of Extramural Research Programs at Fox Chase Cancer Center, is being honored by the Association of Community Cancer Centers with their Annual Clinical Care Achievement Award. Engstrom will receive the award at the organization’s 30th National Oncology Conference in Boston on October 4, 2013.
The Association of Community Cancer Centers promotes the entire continuum of quality cancer care for patients and communities. The organization strives to help oncology professionals adapt to the complex challenges of program management, reimbursement restraints, hospital consolidation and mergers, and legislation and regulations that threaten to compromise the delivery of quality cancer care. Their Annual Achievement Award is given to distinguished individuals who have made outstanding contributions to community cancer care and to patients with cancer.
Engstrom has devoted his professional and academic career to improving cancer prevention and early detection research and service. He established the first Cancer Prevention and Control Program in an NCI-designated cancer center at Fox Chase in 1979. Twelve years later, he established a highly successful and ongoing training and career development program that has groomed national leaders in cancer prevention and control research.
He has served as an advisor on some of the most influential cancer prevention and screening boards. These include the American Cancer Society, Philadelphia Division; the National American Cancer Society; the American Association of Cancer Institutes; the American Society of Clinical Oncology; and the National Cancer Institute.
In addition, he is a founding member of the National Comprehensive Cancer Network Patient Guideline Committee. He is a worldwide spokesperson for the national guidelines to screen, diagnose, manage, and support cancer patients.
Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence five consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.
For more information, call 888-369-2427